Eterna Therapeutics
ERNA
$1.86
Share price
4.21%
Change (1 day)
-40.16%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Net assets
Net assets on the balance sheet as of December 2023 : $2.23 M
According to Eterna Therapeutics's latest financial reports the company has $2.23 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Eterna Therapeutics - Net assets on balance sheet (from 2020 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $12.1 M | -52.53% |
| 2021-12-31 | $25.5 M | 232.99% |
| 2020-12-31 | $7.65 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $82.20 B | 3,681,198.70% | 🇫🇷 France |
 Baxter BAX | $8.46 B | 379,120.78% | 🇺🇸 USA |
 Omeros Corporation OMER | -$13.96 M | -724.81% | 🇺🇸 USA |
 Geron GERN | $0.24 B | 11,003.85% | 🇺🇸 USA |
 Genetic Technologies GENE | $3.28 M | 46.98% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 363,805.06% | 🇮🇱 Israel |
 Bio-Techne TECH | $1.96 B | 87,833.72% | 🇺🇸 USA |